Our data showing a predominance of GATA-3+ Th2 cells, and low numbers of T-bet+ Th1 cells, in NSCLC tumors, are in accordance with a previous report in which cytokines were quantified by ELISA in tumor tissue homogenates (55). The gene discussed is GATA3; the disease is non-small cell lung carcinoma.